vendredi 20 septembre 2019

Onco Actu du 20 septembre 2019


1.4 BIOLOGIE - TECHNOS, MODÈLES



Personalized disease models help to fight pediatric cancers [Science Advisory Board]











3.1.1 PRÉVENTION - TABAC - E-CIGS



It’s safest to avoid e-cigarettes altogether – unless vaping is helping you quit smoking [The Conversation]











Number of vaping-related illnesses in U.S. has spiked, CDC says [STAT]











Vaping Illnesses Increase to 530 Probable Cases, C.D.C. Says [NY Times]










Is It Time to Quit Vaping? [NY Times]











4.3 DÉP., DIAG. & PRONO. - INDUSTRIELS



The Importance of Hereditary Cancer Testing for Patients with Pancreatic Cancer [Myriad]











5. TRAITEMENTS



Children being denied new cancer drugs [BBC News]











Study signals new era of precision medicine for children with cancer [Institute of Cancer Research]










5.10 TRAITEMENTS - ESSAIS



Success of nearly half of European cancer drug trials 'exaggerated' due to bias: report [Fierce Biotech]











Almost half of all cancer drug trials show bias and exaggeration [Pharmafile]











Cancer drug trials often at risk of bias, study finds [Biopharma Dive]










Cancer trials aimed at 'surrogate' targets miss bigger mark — study [EndPoints]











5.12.13 IMMUNOTHÉRAPIES - BIOMARQUEURS



E-sniffer predicts non-responders to lung cancer immunotherapy [Reuters]











5.2 PHARMA



Novartis doesn't wait for FDA investigation and halts distribution of its generic Zantac [Fierce Pharma]











Novartis stops distributing generic Zantac as carcinogen concerns rise [Biopharma Dive]











5.2.3 PHARMA - ÉCONOMIE



Boundless Bio uncloaks with $46M to create new cancer drugs aimed at extrachromosomal DNA [Fierce Biotech]











Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M [Xconomy]










A New Approach To Cancer Treatment [Boundless Bio]











'A fourth revolution in cancer therapies': ARCH-backed Boundless Bio flashes big check, makes bigger promises in debut [EndPoints]











5.6 ESMO



Pfizer Presents Scientific Advancements in Cancer Care at the ESMO Congress 2019 Highlighting Expanded Portfolio [Pfizer]











Bristol-Myers Squibb Research at ESMO Demonstrates Breadth of Oncology Development Program and Focus on Improving Overall Survival Across Multiple Cancers [BMS]











Janssen to Highlight Depth of Prostate Cancer and Solid Tumor Portfolios with Multiple Data Presentations at ESMO 2019 [Janssen]











6.10.1 POLITIQUES (USA)



Trump says it’s ‘great to see’ Pelosi’s drug pricing plan [STAT]











Understanding The House Democrats’ Drug Pricing Package [Health Affairs]










U.S. Speaker Pelosi unveils drug price plan, Trump welcomes it [Reuters]











6.6 PUBLICATIONS



New Journal Seeks Typically Overlooked Studies [The Scientist]











6.7 DMP, BIG DATA & APPLIS



DeepMind's health team makes the jump to Google with some NHS partnerships in tow [Fierce Biotech]











6.7.1 IA/BIOINFORMATIQUE



New AI laboratory for the NHS [BMJ]